Objective: The study was aimed to investigate the inhibitory effect of ethanolic extract of Curanga fel-terrae leaves (EECFL) against acetylcholine (ACh)-induced contraction of the ACh-muscarinic-3 receptor.
INTRODUCTION
Curanga fel-terrae (Lour.) Merr. in Indonesia known as pugun tano is one of the plants of the family Linderniaceae. This plant is found in Asia such as China, India, Indonesia, Philippine, Malaysia, and Myanmar. In Indonesia, the plant can be found in Sumatra, Java, Kalimantan, and Maluku [1] . Rural communities use the leaves and latex to cure abdominal pain, cough, scabies, bruising, inflammation, and asthma. Previous research suggests that these plants contain glycosides [2, 3] , flavonoids [4] , saponins [5] , terpenoids, curangin, and bitter substances [6] . C. fel-terrae has been studied have a pharmacological activity as anthelmintic [7] , antidiabetic [8, 9] , antibreast cancer [10] [11] [12] , diuretic effect [13] , and cardioprotective effect [14] .
Epidemiology study showed almost 20% people in the world suffer from diseases associated with allergy and asthma [15] . Almost 300 million people suffer from asthma, especially asthma which related to allergy. The main risk factors of asthma in developed and poor countries is caused by allergies and respiratory tract irritation induced by allergens and particles in the air [16] . The respiratory diseases such as asthma, chronic bronchitis, and emphysema were the fourth reason of death in Indonesia [17] .
Important nervous system associated with human lung is the cholinergic nervous system. Cholinergic or parasympathetic nervous system was largely expressed in the proximal airways and decreases toward the periphery. Acetylcholine (Ach) released by the parasympathetic system plays an important role in controlling the airways and mucus release from submucosal glands, as well as goblet cells in the airway epithelium [18] . In human airway muscarinic receptors overexpressed in M 1 , M 2 , and M 3 types [18, 19] . Excessive activation on the cholinergic nerve can cause of respiratory tract disorders [20] .
Indonesia has great biodiversity that potential for the discovery of new drugs. Therefore, it is possible to find a new alternative treatment for asthma from natural resources. Although C. fel-terrae has been used traditionally by the community as a medicine such as for asthma, the scientific data associated with pharmacological activity reports still lack.
Based on this reason, researchers are interested in evaluating the ethanolic extract of C. fel-terrae leaves (EECFL) in the respiratory tract primarily on the contraction induced by ACh on ACh receptorsmuscarinic-3.
MATERIALS AND METHODS

Materials
Drugs and chemicals used in this study were ACh, dimethyl sulfoxide (Sigma-Aldrich, USA), and ethanol 96% (Merck). Instrument used in this experiment was organ bath PowerLab (ML0146/50, PanLab, ADInstruments, New Zealand).
Tissue preparation
Male guinea pig weighing 300-500 g (3-4 months) were housed in a room with controlled temperature and lighting and allowed free access to chow and water. The animals were sacrificed by cervix dislocation. Trachea was dissected out and the connective tissue was gently removed. Subsequently, the rings were cut with a length of 8-9 rings and both sides cartilage was bound with which connected to the transducer MLT0201 (PanLab, ADInstrument) connected with PowerLab T15-0676 (PanLab, ADInstrument) [21] [22] [23] .
Inhibitory effect of EECFL to the contraction induced by agonist ACh-muscarinic-3 receptor After equilibration, guinea-pig tracheal was contracted gradually with series concentration of ACh (10 −8 -10 −3 M) to the tissue bath as a control concentration-response curve until maximum contraction was achieved. Subsequently, ACh was washed out of the bath and complete relaxation of tracheal allowed. The ability of EECFL to challenge AChinduced tracheal contraction was tested using cumulative addition of ACh after 20 minutes preincubation of the tracheal with extract (0.5 mg/ml, 1 mg/ml, 2 mg/ml, 4 mg/ml) or with control. All the experiment conducted using Krebs buffer with gas flowing O 2 :CO 2 (95%: 5%) [21] [22] [23] .
Calculation of responses and data presentation
The highest contraction induced by ACh was considered the maximum response. Log concentration-response (LCR) curves were constructed. The effects of different concentrations of EECFL were expressed as a percentage of maximum inhibitory response (100%). R max values represented the maximum contractile response induced by ACh. Median effective concentration (EC 50 ) was obtained from the LCR of isolated tracheal [24] .
Competitive or noncompetitive antagonism was evaluated from the rightward shift of the ACh on LCR curve, depression of the maximum response, and the Lineweaver-Burk double-reciprocal plot (DRP). Competitive antagonism, a right-shifted curve is parallel to the agonistonly curve, and the maximal response is obtainable even in the presence of the antagonist. In non-competitive antagonism, a right-shifted curve is not parallel to the agonist-only curve, and the maximal response is unattainable in the presence of the antagonist [24] .
A DRP of the contractile response (1/R, y-axis) was plotted against the ACh concentration (1/[ACh], x-axis), producing a straight line with positive and negative intercepts on the y-axis and x-axis, respectively. In competitive antagonism, a plot yields straight lines which have the same intercept on y-axis, while with non-competitive antagonism, a plot shows the same trend as competitive antagonism (i.e., straight lines), but the intercepts do not. The y-intercept was calculated from the straight line equation: Linearity over the ACh concentration was evaluated by quantification of the mean linear regression of the five replicates and calculation of the correlation coefficient (R 2 ) [24] .
Statistical analysis
−log EC 50 and R max were analyzed using SPSS 17 version. The contractile responses to cumulative ACh were analyzed using one-way analysis of variance followed by a Tukey post-hoc test. All data are presented as mean±standard error of the mean and p<0.05 were considered significant.
RESULTS
The effect of EECFL on isolated guinea pig tracheal to the contraction induced by agonist compound could be observed through the changes of isolated tracheal smooth muscle contraction % response with the addition of agonist concentration, ACh (10 −8 -10 −3 M) on tracheal organ.
Series concentration of ACh-induced the contraction on guinea-pig isolated tracheal smooth muscle. Response percentage of tracheal smooth muscle increased with the addition of ACh concentration. The maximum ACh concentration for tracheal smooth muscle contraction was 10 −3 M. The next given concentration (3×10 −3 M) was not change the percentage of smooth muscle contraction (Fig. 1) .
While the end of contraction from each treatment showed 100% contraction. From the Sigmoid graph, it could be concluded that the addition of pugun tano ethanolic extract resulted antagonist effect on ACh-induced contraction.
Inhibition of contraction by the extracts was confirmed by comparing the value of pD 2 (−log EC 50 ) in Fig. 2 and it showed that the addition of EECFL 1, 2, and 4 mg/ml resulted the decrease of pD 2 value of ACh (p<0.05). While 0.5 mg/ml EECFL concentration showed not different of pD 2 value compared to the control. This study shows that EECFL at 1, 2, and 4 mg/ml concentration occur inhibitory effect on tracheal smooth muscle contraction-stimulated by ACh. Increasing concentration of the extract further reduces the potential agonists induce tracheal smooth muscle contraction. These results demonstrate the inhibitory effect of the EECFL is dose dependent manner.
The results of this study indicate that the contraction induced by ACh is significantly inhibited by EECFL at the concentrations of 1, 2, and 4 mg/ml. Tissue incubation with varying concentrations of EECFL before contractions gradually by ACh produces right-shifts contraction curve (Fig. 1) without causing a decrease in maximal contraction (R max ) ( Table 1) . Right-shifts contraction curve indicates that it takes a greater amount of ACh to produce the same effect of contraction due to the obstacles made by the extract. This inhibition does not lowering the ability of ACh to achieve maximum contraction. Both of these results indicate that EECFL occurs the ability to inhibit contraction of ACh.
To find out how the characteristic antagonist of the extracts uses DRP analysis of ACh. DRP provides an easy search antagonism mechanism of natural ingredients such as extracts. DRP results (Table 1) shows the regression equation of the average ACh contraction and ACh+EECFL, y-intercept, and correlation coefficient. The 1/y-intercept average value of each extract was 0.013 (Fig. 3, Table 3 ). The value is not different from the intercept of ACh (control), it can be concluded that the addition of the EECFL resulting competitive antagonist effect on the contraction induced by ACh.
DISCUSSION
ACh administrations have increased tracheal smooth muscle contraction through ACh-M 3 receptor stimulation [25] [26] [27] . ACh-M 3 receptors expressed in various types of cells and this receptor cellular signal is mediated by ACh. These receptors play an important role in ] i modulates calcium bond with calmodulin which will activating myiosin light chain kinase (MLCK). MLCK activation results are cross-linking between actin and myosin. The bond formation between myosin and actin and this may lead to contraction of the smooth muscle [26, 29] .
Stimulation of ACh-M 3 receptor on the smooth muscle of the airways can cause airway disorders such as bronchoconstriction and increased mucus production from the submucosal glands [18, [30] [31] [32] . It is known that human muscarinic receptor is predominantly expressed in smooth muscle cells, epithelial cells, and fibroblasts [28] .
Inhibition of ACh-M reseptor induced contraction by extract indicated that the chemical compounds contained in the extracts possess work at these receptors. Several compounds have been reported posses relaxation effect on smooth muscle muscarinic mediated-receptor such as flavonoid. Galangin, flavonoids have an inhibitory effect on bladder smooth muscle contractility [33] . Flavonoids possess antagonist activity on ACh-M 3 receptor [34, 35] . Steroidal saponins have bronchial asthma inhibitory via inhibition of mediator release such as prostaglandins, histamine, serotonin and bradykinin [36] . Mahapatra and Pradhan also reported that alkaloids, flavonoids, saponins, tannins, polyphenol antioxidant, and coumarins like biologically active compounds that might be responsible for the anti asthmatic activity [37] . Relevance to that result, C. fel-terrae on this study also contain flavonoids, saponins, steroids, and triterpenes. Further research is needed to determine the chemical compounds of which responsible for the inhibitory effect of ACh-muscarinic-3 receptor.
CONCLUSION
The EECFL showed competitive antagonist effect on ACh-muscarinic-3 receptor. 
